AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 78 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,130,000 | -47.2% | 150,000 | -76.0% | 0.78% | -51.9% |
| Q4 2014 | $2,140,000 | -64.0% | 623,892 | -63.0% | 1.61% | -23.4% |
| Q3 2014 | $5,952,000 | -48.3% | 1,685,990 | +22.3% | 2.10% | -73.1% |
| Q2 2014 | $11,515,000 | +31.0% | 1,379,099 | -0.4% | 7.82% | +5.4% |
| Q1 2014 | $8,789,000 | -16.0% | 1,384,042 | -5.7% | 7.41% | -6.2% |
| Q4 2013 | $10,468,000 | +8.8% | 1,468,102 | +14.4% | 7.91% | +6.5% |
| Q3 2013 | $9,624,000 | – | 1,283,161 | – | 7.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |